OTX-14-002: Device Exposure Registry

Ocular Therapeutix, Inc.

Overview

The objective of the study is to collect post-approval data relative to the incidence of endophthalmitis for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions

Study Type

OBSERVATIONAL

Conditions

Endophthalmitis

Interventions

ReSure SealantDEVICE

Eligibility

Sex: ALL

Medical Language ↔ Plain English

All patients that receive at least one application of the ReSure Sealant on the operative eye following cataract surgery will be enrolled.

Outcomes

Primary Outcomes

Occurrence of endophthalmitis

Time frame: Day 30

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.